A retrospective case study of sunitinib treatment in three patients with Von Hippel-Lindau disease

Von Hippel-Landau (VHL) disease is characterized by malignant and benign tumors in multiple organs. Sunitinib, a tyrosine kinase inhibitor, has been clinically available for treating sporadic patients with recurrent or unresectable and metastatic clear renal cell carcinomas (cRCCs) and metastatic le...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Gang, Liu, Qiuli, Tong, Dali, Liu, Gaolei, Yi, Yuting, Zhang, Jun, Zhang, Yao, Wang, Lin-ang, Wang, Luofu, Chen, Rongrong, Guan, Yanfang, Yi, Xin, Lan, Weihua, Jiang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Clinical Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154838/
https://www.ncbi.nlm.nih.gov/pubmed/29947576
http://dx.doi.org/10.1080/15384047.2018.1470732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154838/
https://www.ncbi.nlm.nih.gov/pubmed/29947576
http://dx.doi.org/10.1080/15384047.2018.1470732

Ejemplares similares